91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Zidovudine API Market Research Report 2023

Global Zidovudine API Market Research Report 2023

Publication ID: 
PB504246612
Publication Date: 
May 22, 2023
Pages: 
96
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Specialty Chemicals [2]
Manufacturing (Chemicals) [3]
Chemicals [4]
Description: 

Zidovudine(CAS锛�30516-87-1) is a nucleoside analogue and reverse transcriptase inhibitor used in combination with other agents in the therapy and prophylaxis of the human immunodeficiency virus (HIV) infection and the acquired immunodeficiency syndrome (AIDS).
The global Zidovudine API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Zidovudine API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Zidovudine API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Zidovudine API include Mylan, Hetero Drugs, HEC Pharm, ZHEJIANG LANGHUA PHARMACEUTICAL, Shanghai Shyndec Pharmaceutical, Shanghai Desano Bio-Pharmaceutical, Cipla, Nortec Quimica and Globe Quimica Ltda, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Zidovudine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zidovudine API.
The Zidovudine API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Zidovudine API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zidovudine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Mylan
Hetero Drugs
HEC Pharm
ZHEJIANG LANGHUA PHARMACEUTICAL
Shanghai Shyndec Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
Cipla
Nortec Quimica
Globe Quimica Ltda
Guangzhou Tosun Pharmaceutical
Segment by Type
Above 98 %
Above 99 %
Segment by Application
Injection
Tablets
Capsules
Others
Production by Region
North America
China
India
Brazil
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zidovudine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Zidovudine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Zidovudine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Zidovudine API Market Overview
1.1 Product Definition
1.2 Zidovudine API Segment by Type
1.2.1 Global Zidovudine API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Zidovudine API Segment by Application
1.3.1 Global Zidovudine API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Injection
1.3.3 Tablets
1.3.4 Capsules
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Zidovudine API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Zidovudine API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Zidovudine API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Zidovudine API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Zidovudine API Production Market Share by Manufacturers (2018-2023)
2.2 Global Zidovudine API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Zidovudine API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Zidovudine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Zidovudine API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Zidovudine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Zidovudine API, Product Offered and Application
2.8 Global Key Manufacturers of Zidovudine API, Date of Enter into This Industry
2.9 Zidovudine API Market Competitive Situation and Trends
2.9.1 Zidovudine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Zidovudine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Zidovudine API Production by Region
3.1 Global Zidovudine API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Zidovudine API Production Value by Region (2018-2029)
3.2.1 Global Zidovudine API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Zidovudine API by Region (2024-2029)
3.3 Global Zidovudine API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Zidovudine API Production by Region (2018-2029)
3.4.1 Global Zidovudine API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Zidovudine API by Region (2024-2029)
3.5 Global Zidovudine API Market Price Analysis by Region (2018-2023)
3.6 Global Zidovudine API Production and Value, Year-over-Year Growth
3.6.1 North America Zidovudine API Production Value Estimates and Forecasts (2018-2029)
3.6.2 China Zidovudine API Production Value Estimates and Forecasts (2018-2029)
3.6.3 India Zidovudine API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Brazil Zidovudine API Production Value Estimates and Forecasts (2018-2029)
4 Zidovudine API Consumption by Region
4.1 Global Zidovudine API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Zidovudine API Consumption by Region (2018-2029)
4.2.1 Global Zidovudine API Consumption by Region (2018-2023)
4.2.2 Global Zidovudine API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Zidovudine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Zidovudine API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Zidovudine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Zidovudine API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Zidovudine API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Zidovudine API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Zidovudine API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Zidovudine API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Zidovudine API Production by Type (2018-2029)
5.1.1 Global Zidovudine API Production by Type (2018-2023)
5.1.2 Global Zidovudine API Production by Type (2024-2029)
5.1.3 Global Zidovudine API Production Market Share by Type (2018-2029)
5.2 Global Zidovudine API Production Value by Type (2018-2029)
5.2.1 Global Zidovudine API Production Value by Type (2018-2023)
5.2.2 Global Zidovudine API Production Value by Type (2024-2029)
5.2.3 Global Zidovudine API Production Value Market Share by Type (2018-2029)
5.3 Global Zidovudine API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Zidovudine API Production by Application (2018-2029)
6.1.1 Global Zidovudine API Production by Application (2018-2023)
6.1.2 Global Zidovudine API Production by Application (2024-2029)
6.1.3 Global Zidovudine API Production Market Share by Application (2018-2029)
6.2 Global Zidovudine API Production Value by Application (2018-2029)
6.2.1 Global Zidovudine API Production Value by Application (2018-2023)
6.2.2 Global Zidovudine API Production Value by Application (2024-2029)
6.2.3 Global Zidovudine API Production Value Market Share by Application (2018-2029)
6.3 Global Zidovudine API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Zidovudine API Corporation Information
7.1.2 Mylan Zidovudine API Product Portfolio
7.1.3 Mylan Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 Hetero Drugs
7.2.1 Hetero Drugs Zidovudine API Corporation Information
7.2.2 Hetero Drugs Zidovudine API Product Portfolio
7.2.3 Hetero Drugs Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Hetero Drugs Main Business and Markets Served
7.2.5 Hetero Drugs Recent Developments/Updates
7.3 HEC Pharm
7.3.1 HEC Pharm Zidovudine API Corporation Information
7.3.2 HEC Pharm Zidovudine API Product Portfolio
7.3.3 HEC Pharm Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 HEC Pharm Main Business and Markets Served
7.3.5 HEC Pharm Recent Developments/Updates
7.4 ZHEJIANG LANGHUA PHARMACEUTICAL
7.4.1 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Corporation Information
7.4.2 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Product Portfolio
7.4.3 ZHEJIANG LANGHUA PHARMACEUTICAL Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 ZHEJIANG LANGHUA PHARMACEUTICAL Main Business and Markets Served
7.4.5 ZHEJIANG LANGHUA PHARMACEUTICAL Recent Developments/Updates
7.5 Shanghai Shyndec Pharmaceutical
7.5.1 Shanghai Shyndec Pharmaceutical Zidovudine API Corporation Information
7.5.2 Shanghai Shyndec Pharmaceutical Zidovudine API Product Portfolio
7.5.3 Shanghai Shyndec Pharmaceutical Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Shanghai Shyndec Pharmaceutical Main Business and Markets Served
7.5.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
7.6 Shanghai Desano Bio-Pharmaceutical
7.6.1 Shanghai Desano Bio-Pharmaceutical Zidovudine API Corporation Information
7.6.2 Shanghai Desano Bio-Pharmaceutical Zidovudine API Product Portfolio
7.6.3 Shanghai Desano Bio-Pharmaceutical Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Shanghai Desano Bio-Pharmaceutical Main Business and Markets Served
7.6.5 Shanghai Desano Bio-Pharmaceutical Recent Developments/Updates
7.7 Cipla
7.7.1 Cipla Zidovudine API Corporation Information
7.7.2 Cipla Zidovudine API Product Portfolio
7.7.3 Cipla Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Cipla Main Business and Markets Served
7.7.5 Cipla Recent Developments/Updates
7.8 Nortec Quimica
7.8.1 Nortec Quimica Zidovudine API Corporation Information
7.8.2 Nortec Quimica Zidovudine API Product Portfolio
7.8.3 Nortec Quimica Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Nortec Quimica Main Business and Markets Served
7.7.5 Nortec Quimica Recent Developments/Updates
7.9 Globe Quimica Ltda
7.9.1 Globe Quimica Ltda Zidovudine API Corporation Information
7.9.2 Globe Quimica Ltda Zidovudine API Product Portfolio
7.9.3 Globe Quimica Ltda Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Globe Quimica Ltda Main Business and Markets Served
7.9.5 Globe Quimica Ltda Recent Developments/Updates
7.10 Guangzhou Tosun Pharmaceutical
7.10.1 Guangzhou Tosun Pharmaceutical Zidovudine API Corporation Information
7.10.2 Guangzhou Tosun Pharmaceutical Zidovudine API Product Portfolio
7.10.3 Guangzhou Tosun Pharmaceutical Zidovudine API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.10.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Zidovudine API Industry Chain Analysis
8.2 Zidovudine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Zidovudine API Production Mode & Process
8.4 Zidovudine API Sales and Marketing
8.4.1 Zidovudine API Sales Channels
8.4.2 Zidovudine API Distributors
8.5 Zidovudine API Customers
9 Zidovudine API Market Dynamics
9.1 Zidovudine API Industry Trends
9.2 Zidovudine API Market Drivers
9.3 Zidovudine API Market Challenges
9.4 Zidovudine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned: 

Mylan
Hetero Drugs
HEC Pharm
ZHEJIANG LANGHUA PHARMACEUTICAL
Shanghai Shyndec Pharmaceutical
Shanghai Desano Bio-Pharmaceutical
Cipla
Nortec Quimica
Globe Quimica Ltda
Guangzhou Tosun Pharmaceutical

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-zidovudine-api-market-research-report-2023

Links
[1] /countries/global[2] /specialty-chemicals[3] /manufacturing-chemicals[4] /chemicals